800-526-2125
Status™ COVID-19/Flu A&B
A rapid immunoassay for the simultaneous direct detection and differential diagnosis of SARS-CoV-2, influenza type A and type B antigens from anterior nasal and nasopharyngeal swab specimens.
- FDA 510K / CLIA WAIVED for use with Anterior Nasal and Nasopharyngeal swab specimens
- COVID-19 -Anterior nasal - PPA 97.4% , NPA 100% . Nasopharyngeal -PPA 95.5%, NPA 99.7%
- FLU A - Anterior nasal - PPA 91.5%, NPA 99.5%. Nasopharyngeal - PPA 94.1%, NPA 99.4%.
- FLU B - Anterior nasal - PPA 90.2%, NPA 99.8%. Nasopharyngeal - PPA 92.7%, NPA 100%
- 28 month shelf-life from date of manufacture • Visually read in 15 minutes
| ORDERING INFORMATION | ||
|---|---|---|
| PRODUCT | # OF TESTS | ITEM # |
| Status™ Covid-19/Flu A&B | 25 | 33225 |
